These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8995004)

  • 1. Oestrogen replacement therapy and risk of hepatobiliary disease in postmenopausal women.
    van Erpecum KJ; van Berge Henegouwen GP
    Br J Clin Pract Suppl; 1996 Sep; 86():9-13. PubMed ID: 8995004
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K; Oger E
    Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risk in postmenopausal women using estrogen-only therapy.
    Lyytinen H; Pukkala E; Ylikorkala O
    Obstet Gynecol; 2006 Dec; 108(6):1354-60. PubMed ID: 17138766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study.
    Canonico M; Oger E; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
    J Thromb Haemost; 2006 Jun; 4(6):1259-65. PubMed ID: 16706969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do the cardiovascular disease risks and benefits of oral versus transdermal estrogen therapy differ between perimenopausal and postmenopausal women?
    Clarkson TB; Karas RH
    Menopause; 2007; 14(6):963-7. PubMed ID: 17909452
    [No Abstract]   [Full Text] [Related]  

  • 6. Oestrogen therapy: oral versus non-oral administration.
    von Schoultz B
    Gynecol Endocrinol; 2009 Sep; 25(9):551-3. PubMed ID: 19479596
    [No Abstract]   [Full Text] [Related]  

  • 7. Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tarda.
    Bulaj ZJ; Franklin MR; Phillips JD; Miller KL; Bergonia HA; Ajioka RS; Griffen LM; Guinee DJ; Edwards CQ; Kushner JP
    J Lab Clin Med; 2000 Dec; 136(6):482-8. PubMed ID: 11128750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patch instead of pill: a safer menopausal estrogen?
    Cushman M
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):136-7. PubMed ID: 20089948
    [No Abstract]   [Full Text] [Related]  

  • 9. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormone replacement therapy and thrombotic risk: beauty is only skin deep.
    Rosendaal FR
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):684-5. PubMed ID: 18797429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.
    Canonico M; Olié V; Carcaillon L; Tubert-Bitter P; Scarabin PY;
    Thromb Haemost; 2008 Jan; 99(1):246-8. PubMed ID: 18217166
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer issues.
    Marsden J; Sturdee D
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study.
    Sonnet E; Lacut K; Roudaut N; Mottier D; Kerlan V; Oger E
    Clin Endocrinol (Oxf); 2007 May; 66(5):626-31. PubMed ID: 17492948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study.
    Dew JE; Wren BG; Eden JA
    Climacteric; 2002 Jun; 5(2):151-5. PubMed ID: 12051110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
    Canonico M; Oger E; Plu-Bureau G; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
    Circulation; 2007 Feb; 115(7):840-5. PubMed ID: 17309934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics and efficacy of different estrogens are not equivalent.
    Ansbacher R
    Am J Obstet Gynecol; 2001 Feb; 184(3):255-63. PubMed ID: 11228470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal hormone therapy: from monkey glands to transdermal patches.
    Davis SR; Dinatale I; Rivera-Woll L; Davison S
    J Endocrinol; 2005 May; 185(2):207-22. PubMed ID: 15845914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progesterone+estrogen increased the risk of dementia in postmenopausal women. Surprising results of the WHIM study].
    Fried G
    Lakartidningen; 2003 Sep; 100(36):2742-3. PubMed ID: 14558187
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dermatoses caused by estrogens and progesterone: an upcoming nosology].
    Estève E
    Ann Dermatol Venereol; 1998 Aug; 125(8):484-5. PubMed ID: 9747310
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormone replacement therapy use and variations in the risk of breast cancer.
    Opatrny L; Dell'Aniello S; Assouline S; Suissa S
    BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.